SCYNEXIS Inc (SCYX) stock
SCYXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3072% below fair value
$2.85−0.06 (-2.06%)
Close on Nov 17, 2026Market cap $28.36MP/E –Yield –
Scynexis total assets
Total assets on the balance sheet at the end of each period.
Scynexis's total assets was $74.97M at Jun 30, 2026. For fiscal 2025 it was $59.03M, down 34.9% from the year before. Over ten years it grew 1.8% a year on average. The highest annual figure on record is $128.41M in fiscal 2023.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $59.03M | -34.9% |
| FY2024 | Dec 31, 2024 | $90.64M | -29.4% |
| FY2023 | Dec 31, 2023 | $128.41M | +46.2% |
| FY2022 | Dec 31, 2022 | $87.81M | -26.7% |
| FY2021 | Dec 31, 2021 | $119.84M | +16.9% |
| FY2020 | Dec 31, 2020 | $102.54M | +79.4% |
| FY2019 | Dec 31, 2019 | $57.15M | +7.5% |
| FY2018 | Dec 31, 2018 | $53.17M | +16.0% |
| FY2017 | Dec 31, 2017 | $45.85M | -23.3% |
| FY2016 | Dec 31, 2016 | $59.79M | +21.3% |
| FY2015 | Dec 31, 2015 | $49.27M | +24.2% |
| FY2014 | Dec 31, 2014 | $39.67M | +220.3% |
| FY2013 | Dec 31, 2013 | $12.39M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $74.97M | +23.5% |
| Q1 FY2026 | Mar 31, 2026 | $77.63M | +14.3% |
| Q4 FY2025 | Dec 31, 2025 | $59.03M | -34.9% |
| Q3 FY2025 | Sep 30, 2025 | $51.07M | -48.4% |
| Q2 FY2025 | Jun 30, 2025 | $60.69M | -43.7% |
| Q1 FY2025 | Mar 31, 2025 | $67.92M | -42.6% |
| Q4 FY2024 | Dec 31, 2024 | $90.64M | -29.4% |
| Q3 FY2024 | Sep 30, 2024 | $99.04M | -33.3% |
| Q2 FY2024 | Jun 30, 2024 | $107.81M | -30.4% |
| Q1 FY2024 | Mar 31, 2024 | $118.25M | +68.2% |
| Q4 FY2023 | Dec 31, 2023 | $128.41M | +46.2% |
| Q3 FY2023 | Sep 30, 2023 | $148.55M | +32.3% |
| Q2 FY2023 | Jun 30, 2023 | $154.86M | +14.2% |
| Q1 FY2023 | Mar 31, 2023 | $70.30M | -37.0% |
| Q4 FY2022 | Dec 31, 2022 | $87.81M | -26.7% |
| Q3 FY2022 | Sep 30, 2022 | $112.29M | +2.2% |
| Q2 FY2022 | Jun 30, 2022 | $135.61M | +12.0% |
| Q1 FY2022 | Mar 31, 2022 | $111.56M | +11.5% |
| Q4 FY2021 | Dec 31, 2021 | $119.84M | +16.9% |
| Q3 FY2021 | Sep 30, 2021 | $109.88M | +199.0% |
| Q2 FY2021 | Jun 30, 2021 | $121.13M | +167.6% |
| Q1 FY2021 | Mar 31, 2021 | $100.07M | +141.1% |
| Q4 FY2020 | Dec 31, 2020 | $102.54M | +79.4% |
| Q3 FY2020 | Sep 30, 2020 | $36.75M | +8.7% |
| Q2 FY2020 | Jun 30, 2020 | $45.27M | +10.2% |
| Q1 FY2020 | Mar 31, 2020 | $41.51M | -7.9% |
| Q4 FY2019 | Dec 31, 2019 | $57.15M | +7.5% |
| Q3 FY2019 | Sep 30, 2019 | $33.82M | -34.5% |
| Q2 FY2019 | Jun 30, 2019 | $41.07M | -29.2% |
| Q1 FY2019 | Mar 31, 2019 | $45.07M | -31.2% |
| Q4 FY2018 | Dec 31, 2018 | $53.17M | +16.0% |
| Q3 FY2018 | Sep 30, 2018 | $51.65M | +4.1% |
| Q2 FY2018 | Jun 30, 2018 | $58.05M | +12.0% |
| Q1 FY2018 | Mar 31, 2018 | $65.49M | +15.6% |
| Q4 FY2017 | Dec 31, 2017 | $45.85M | -23.3% |
| Q3 FY2017 | Sep 30, 2017 | $49.62M | -18.7% |
| Q2 FY2017 | Jun 30, 2017 | $51.84M | – |
| Q1 FY2017 | Mar 31, 2017 | $56.66M | – |
| Q4 FY2016 | Dec 31, 2016 | $59.79M | – |
| Q3 FY2016 | Sep 30, 2016 | $61.01M | – |
See a number that looks wrong?